Eyetech Pharmaceuticals' IPO

Eyetech Pharmaceuticals raised a round of funding on January 30, 2004. Investors include Public.

Eyetech Pharmaceuticals was founded to discover and develop new drugs to reduce and prevent serious vision loss caused by eye disease. Eyetech's lead product, EYE001, addresses the two leading causes …

Articles about Eyetech Pharmaceuticals' IPO: